Evidence map›Paper›PMID 27114526›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Relevance of the COPI complex for Alzheimer's disease progression in vivo.

Karima Bettayeb, Basaraj V Hooli, Antonio R Parrado, Lisa Randolph, Dante Varotsis, Suvekshya Aryal, Jodi Gresack, Rudolph E Tanzi, Paul Greengard, Marc Flajolet

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Amyloid-β "Co-assembles" with Coatomer Subunit Delta (δ-COP).The journal of physical chemistry letters · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Relationship BetweenJournal of Alzheimer's disease reports · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Karima BettayebLaboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, NY 10065;
Basaraj V HooliGenetics and Aging Research Unit, MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129.
Antonio R ParradoGenetics and Aging Research Unit, MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129.
Lisa RandolphLaboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, NY 10065;
Dante VarotsisLaboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, NY 10065;
Suvekshya AryalLaboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, NY 10065;
Jodi GresackLaboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, NY 10065;
Rudolph E TanziGenetics and Aging Research Unit, MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129.
Paul GreengardLaboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, NY 10065; flajolm@rockefeller.edu greengard@rockefeller.edu.
Marc FlajoletLaboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, NY 10065; flajolm@rockefeller.edu greengard@rockefeller.edu.

Funding

THE MECHANISMS OF y-SECRETASE REGULATIONP01AG009464 · NIA · ROCKEFELLER UNIVERSITY · PI KIM, YONG I · 1991 to 2011
$15.0M
Identification and Characterization of Novel AD GenesR37MH060009 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI TANZI, RUDOLPH EMILE · 2003 to 2012
$7.6M
SEARCH FOR NOVEL ALZHEIMERS DISEASE GENESR01MH060009 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI TANZI, RUDOLPH EMILE · 1999 to 2017
$5.4M
MECHANISMS FOR SELECTIVE REGULATION OF GAMMA-SECRETASE (AG09464-21A1 PROJ 2R01AG047781 · NIA · ROCKEFELLER UNIVERSITY · PI GREENGARD, PAUL · 2013 to 2017
$2.9M
SELECTIVE CELL VULNERABILITY IN ALZHEIMERS DISEASE (AG09464-21A1 PROJ4)RF1AG047779 · NIA · ROCKEFELLER UNIVERSITY · PI ROUSSARIE, JEAN-PIERRE · 2014 to 2014
$2.0M
NIA NIH HHS P01 AG009464NIA NIH HHS R01 AG047781NIA NIH HHS RF1 AG047779NIMH NIH HHS R01 MH060009NIMH NIH HHS R37 MH060009
6 · The paper itself

Abstract

Cellular trafficking and recycling machineries belonging to late secretory compartments have been associated with increased Alzheimer's disease (AD) risk. We have shown that coat protein complex I (COPI)-dependent trafficking, an early step in Golgi-to-endoplasmic reticulum retrograde transport, affects amyloid precursor protein subcellular localization, cell-surface expression, as well as its metabolism. We present here a set of experiments demonstrating that, by targeting subunit δ-COP function, the moderation of the COPI-dependent trafficking in vivo leads to a significant decrease in amyloid plaques in the cortex and hippocampus of neurological 17 mice crossed with the 2xTg AD mouse model. Remarkably, an improvement of the memory impairments was also observed. Importantly, human genetic association studies of different AD cohorts led to the identification of 12 SNPs and 24 mutations located in COPI genes linked to an increased AD risk. These findings further demonstrate in vivo the importance of early trafficking steps in AD pathogenesis and open new clinical perspectives.

Indexed as

Disease ProgressionAlzheimer DiseaseAnimalsBrainCoat Protein Complex IMaleMiceMice, Inbred C57BLPlaque, AmyloidProtein TransportSubcellular FractionsCoat Protein Complex IAlzheimerCOPIEWAS studiesGWAS studieshuman genetic

Identifiers

PMID27114526
PMCPMC4868486

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.